Combo Extends OS in Patients 65+ with Ph+ ALL

Model Predicts AI Non-adherence Risk

Lung-MAP Shows Potential of Public-Private Partnerships

ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023

Bladder Cancer Subtype Association with Response

FORTE, a Colorectal Cancer Prevention Clinical Trial, accrues its first 1,000 participants

New Vice Chair named for NRG Health Disparities Committee

Pembro before Surgery Shrinks Advanced Melanomas

Alliance Presents Detailed Results from Phase III CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors at ESMO 2023

Adjuvant Benefit in Highest Risk Clear-Cell RCC